By McCord Pagan ( December 8, 2021, 7:03 PM EST) -- Chinese lung cancer-focused biotechnology company Avistone Pharmaceuticals said Wednesday it raised more than $200 million in funding in a round that included Vivo Capital, Bain Capital and Primavera Capital....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.